These medical and wellness formulations are an advanced line of pharmaceutical-grade cannabis formulas containing varying ratios of cannabidiol (“CBD”) and tetrahydrocannabinol (“THC”). The portfolio contains a full formulary of preparations including oral, sublingual, topical, and transdermal deliveries that have controlled dosing, enhanced absorption and stability studies supported by pre-clinical data. The advanced formulary is marketed with consumer, patient and medical community education and training.

Avicanna’s medical and wellness portfolio also forms the foundation of the Company’s pharmaceutical pipeline with the contribution of the formulations that form the basis of the products as well as the data generated from sales and participation of the products in real world evidence studies.